Φορτώνει......
A phase 2 trial of long-acting TransCon growth hormone in adult GH deficiency
TransCon growth hormone is a sustained-release human growth hormone prodrug under development in which unmodified growth hormone is transiently linked to a carrier molecule. It is intended as an alternative to daily growth hormone in the treatment of growth hormone deficiency. This was a multi-cente...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Endocr Connect |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Bioscientifica Ltd
2017
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5424766/ https://ncbi.nlm.nih.gov/pubmed/28196799 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/EC-17-0007 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|